Top insider trades (week of Feb 3)

Happy Saturday!

Welcome to this week’s edition of CEO Watcher. This is the only tool that tracks the returns of insiders so we know which insider trades are worth copying.

This week we found:

• The $KALV insider trade from Thursday, Jan 25th is up 25%

• CFO at $RLMD with 87% 3-month returns bought stock

• and more…

Have a great weekend and thanks for reading!

Connor

💰 Previous Winner

This $KALV insider trade we highlighted in the Thursday, January 25th premium email is already up 25%.

Upgrade to CEO Watcher Premium to get the top insider trades as soon as they happen.

👀 Top Insider Trades this Week

🥇 Chief Financial Officer at RELMADA THERAPEUTICS, INC. ($RLMD)

The Chief Financial Officer purchased 32,675 shares at $3.85/share ($126K total) which increased their holdings by 1466.6%. The current price is $4.57 (+19%). Their median purchase size is $22,494.00 and this is their 1st largest purchase out of 5 all time. (trade link)

Historic Returns
1m returns: 45% weighted | 43% median | 100% win rate (2/2)
3m returns: 87% weighted | 87% median | 100% win rate (2/2)
6m returns: 34% weighted | 35% median | 100% win rate (2/2)
1y returns: 11% weighted | 13% median | 50% win rate (1/2)

Note: 2 other executives also bought the stock. This is up 8% since we highlighted it in Thursday’s premium email

🥈 10% Owner at KalVista Pharmaceuticals, Inc. ($KALV)

The 10% Owner purchased 91,804 shares at $14.05/share ($1.29M total) which increased their holdings by 2.0%. The current price is $15.30 (+8.9%). Their median purchase size is $1.73M and this is their 7th largest purchase out of 11 all time. (trade link)

Historic Returns
1m returns: 75% weighted | 13% median | 100% win rate (5/5)
3m returns: 46% weighted | 30% median | 50% win rate (2/4)
6m returns: 19% weighted | 3% median | 50% win rate (2/4)
1y returns: 37% weighted | 20% median | 50% win rate (2/4)

Note: 7th purchase in the last month. The stock is up 6% since we highlighted it in Tuesday’s premium email

🥉 10% Owner at Adicet Bio, Inc. ($ACET)

The 10% Owner purchased 3,125,000 shares at $2.40/share ($7.50M total) which increased their holdings by 165.4%. The current price is $2.89 (+20%). Their median purchase size is $4.50M and this is their 9th largest purchase out of 26 all time. (trade link)

Historic Returns
1m returns: 35% weighted | 24% median | 80% win rate (20/25)
3m returns: 16% weighted | 14% median | 72% win rate (18/25)
6m returns: 27% weighted | 15% median | 56% win rate (14/25)
1y returns: 28% weighted | -2% median | 48% win rate (10/21)

Note: Purchased as part of a $98M public offering. The stock is up 9% since we highlighted this trade in Monday’s premium email

Get the insider trades as soon as they happen

By upgrading to CEO Watcher Premium, you get the top insider trades as soon as they happen.

Each morning you get an email with the best insider buys and sells.

CEO Watcher Premium perks:

• Daily email with top insider buys/sells

• Access to the CEO Watcher Premium Portfolio. I took $10,000 out of my retirement account to invest in the stocks we find in the CEO Watcher and Yellowbrick Road newsletters. Help me turn that $10k into $100k (or just watch me lose it all).

• Full access to Yellowbrick Road Premium

Just one profitable trade will pay for a full year (or more) of CEO Watcher Premium. And, I’ll even make a deal with you. If you upgrade to CEO Watcher Premium and don’t get 10x more value than what you paid, I’ll give you your money back at any time with no questions asked.